Evidence map›Paper›PMID 25123189›Full record

ArticleMolecules (Basel, Switzerland)2014

Intracellular diagnostics: hunting for the mode of action of redox-modulating selenium compounds in selected model systems.

Dominika Mániková, Lucia Medvecová Letavayová, Danuša Vlasáková, Pavol Košík, Ethiene Castellucci Estevam, Muhammad Jawad Nasim, Martin Gruhlke, Alan Slusarenko, Torsten Burkholz, Claus Jacob and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Small Molecule Catalysts with Therapeutic Potential.Molecules (Basel, Switzerland) · 2018
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Dominika MánikováDepartment of Genetics, Cancer Research Institute, Vlárska 7, 833 91 Bratislava, Slovakia. dominika.manikova@savba.sk.
Lucia Medvecová LetavayováDepartment of Genetics, Cancer Research Institute, Vlárska 7, 833 91 Bratislava, Slovakia. lucia.letavayova@gmail.com.
Danuša VlasákováDepartment of Genetics, Cancer Research Institute, Vlárska 7, 833 91 Bratislava, Slovakia. exondako@savba.sk.
Pavol KošíkDepartment of Oncology, Cancer Research Institute, Vlárska 7, 833 91 Bratislava, Slovakia. pavol.kosik@savba.sk.
Ethiene Castellucci EstevamDivision of Bioorganic Chemistry, School of Pharmacy, Saarland University, Campus B 2.1, D-66123 Saarbruecken, Germany. ethiene.castellucciestevam@uni-saarland.de.
Muhammad Jawad NasimDivision of Bioorganic Chemistry, School of Pharmacy, Saarland University, Campus B 2.1, D-66123 Saarbruecken, Germany. jawad.nasim@uni-saarland.de.
Martin GruhlkeDepartment of Plant Physiology (BioIII), RWTH Aachen University, D-52056 Aachen, Germany. Martin.Gruhlke@rwth-aachen.de.
Alan SlusarenkoDepartment of Plant Physiology (BioIII), RWTH Aachen University, D-52056 Aachen, Germany. alan.slusarenko@bio3.rwth-aachen.de.
Torsten BurkholzDivision of Bioorganic Chemistry, School of Pharmacy, Saarland University, Campus B 2.1, D-66123 Saarbruecken, Germany. t.burkholz@mx.uni-saarland.de.
Claus JacobDivision of Bioorganic Chemistry, School of Pharmacy, Saarland University, Campus B 2.1, D-66123 Saarbruecken, Germany. c.jacob@mx.uni-saarland.de.
Miroslav ChovanecDepartment of Genetics, Cancer Research Institute, Vlárska 7, 833 91 Bratislava, Slovakia. miroslav.chovanec@savba.sk.
Cancer Research Institute of the Slovak Academy of Sciences · SKSaarland University · DERWTH Aachen University · DEMinistry of Education · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Redox-modulating compounds derived from natural sources, such as redox active secondary metabolites, are currently of considerable interest in the field of chemoprevention, drug and phytoprotectant development. Unfortunately, the exact and occasionally even selective activity of such products, and the underlying (bio-)chemical causes thereof, are often only poorly understood. A combination of the nematode- and yeast-based assays provides a powerful platform to investigate a possible biological activity of a new compound and also to explore the "redox link" which may exist between its activity on the one side and its chemistry on the other. Here, we will demonstrate the usefulness of this platform for screening several selenium and tellurium compounds for their activity and action. We will also show how the nematode-based assay can be used to obtain information on compound uptake and distribution inside a multicellular organism, whilst the yeast-based system can be employed to explore possible intracellular mechanisms via chemogenetic screening and intracellular diagnostics. Whilst none of these simple and easy-to-use assays can ultimately substitute for in-depth studies in human cells and animals, these methods nonetheless provide a first glimpse on the possible biological activities of new compounds and offer direction for more complicated future investigations. They may also uncover some rather unpleasant biochemical actions of certain compounds, such as the ability of the trace element supplement selenite to induce DNA strand breaks.

Indexed as

Models, BiologicalAnimalsCytoplasmDNA DamageHumansNematodaOxidation-ReductionSaccharomyces cerevisiaeSelenium CompoundsTelluriumSelenium CompoundsTellurium

Identifiers

PMID25123189
PMCPMC6271387
OpenAlexW2133750107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.